Support WBURFDA Panel Endorses Gene Therapy For A Form Of Childhood BlindnessPlay03:26Download AudioRob SteinOctober 12, 2017 ShareA panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. (Spark Therapeutics)